ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells

While therapies targeting deficiencies in the homologous recombination (HR) pathway are emerging as the standard treatment for high grade serous ovarian cancer (HGSOC) patients, this strategy is limited to the ~50% of patients with a deficiency in this pathway. Therefore, patients with HR-proficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chi-Wei, Buj, Raquel, Dahl, Erika S., Leon, Kelly E., Aird, Katherine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527645/
https://www.ncbi.nlm.nih.gov/pubmed/33024871
http://dx.doi.org/10.1016/j.heliyon.2020.e05097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527645/
https://www.ncbi.nlm.nih.gov/pubmed/33024871
http://dx.doi.org/10.1016/j.heliyon.2020.e05097

Ejemplares similares